novartis sees blood cancer drug as blockbuster
novartis ag's blood cancer drug inc424 could rake in annual sales of $1 billion, the group's head of oncology told reuters on tuesday, in a boost to the swiss drugmaker's cancer pipeline.
http://feeds.reuters.com/~r/reuters/healthnews/~3/h7i7dmhblpa/us-novartis-bloodcancer-idustre72e6qm20110315
26305
15 Mar 2011 18:40:44
reuters
health